These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8470817)

  • 1. Molecular dosimetry.
    Noble D
    Anal Chem; 1993 Apr; 65(7):353A-355A. PubMed ID: 8470817
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting chemicals causing cancer in animals as human carcinogens.
    Huff J
    Occup Environ Med; 2010 Oct; 67(10):720. PubMed ID: 20837652
    [No Abstract]   [Full Text] [Related]  

  • 3. A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studies.
    Lewis DF; Ioannides C; Parke DV
    Hum Exp Toxicol; 1998 Oct; 17(10):577-86. PubMed ID: 9821022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk assessment: historical perspectives, current issues, and future directions.
    Velazquez SF; Schoeny R; Rice GE; Cogliano VJ
    Drug Chem Toxicol; 1996 Aug; 19(3):161-85. PubMed ID: 8933022
    [No Abstract]   [Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel naïve Bayes classification models for predicting the carcinogenicity of chemicals.
    Zhang H; Cao ZX; Li M; Li YZ; Peng C
    Food Chem Toxicol; 2016 Nov; 97():141-149. PubMed ID: 27597133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro mammalian cell genotoxicity assays: their use and interpretation.
    McGregor D
    Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003
    [No Abstract]   [Full Text] [Related]  

  • 9. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-mutagenic carcinogens are primarily hydrophobic.
    McCoy GD; Rosenkranz HS; Klopman G
    Carcinogenesis; 1990 Jul; 11(7):1111-7. PubMed ID: 2372870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting and predicting the activity of rodent carcinogens.
    Parry JM
    Mutagenesis; 1994 Jan; 9(1):3-5. PubMed ID: 7911554
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-and medium-term carcinogenicity tests: simple initiation-promotion assay systems.
    Tsuda H; Park CB; Moore MA
    IARC Sci Publ; 1999; (146):203-49. PubMed ID: 10353389
    [No Abstract]   [Full Text] [Related]  

  • 13. Returning biology to carcinogenicity testing.
    Wagner BM
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):169-70. PubMed ID: 1539155
    [No Abstract]   [Full Text] [Related]  

  • 14. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically altered mouse models for identifying carcinogens.
    Tennant RW; Stasiewicz S; Mennear J; French JE; Spalding JW
    IARC Sci Publ; 1999; (146):123-50. PubMed ID: 10353386
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of genetically modified animals in carcinogenicity bioassays.
    Maronpot RR
    Toxicol Pathol; 2000; 28(3):450-3. PubMed ID: 10862565
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights of International meeting on Alternative Methods of Carcinogenicity Testing, Leesburg, VA, November 1-3, 2000, Sponsored by the Health and Environmental Sciences Institute.
    Jollow DJ
    J Agromedicine; 2004; 9(2):427-9. PubMed ID: 19785235
    [No Abstract]   [Full Text] [Related]  

  • 18. Which drugs cause cancer? Cancer bioassays. Against.
    Farland WH; Rodan B; Preuss P
    BMJ; 2005 Oct; 331(7521):E389-91. PubMed ID: 16229069
    [No Abstract]   [Full Text] [Related]  

  • 19. Animal studies in potency ranking of carcinogens in Norway.
    Sanner T; Dybing E; Hardeng S; Haug E; Ovrebø S
    Prog Clin Biol Res; 1992; 374():399-414. PubMed ID: 1620715
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: analysis of pharmaceutical experience with decades of rat carcinogenicity testing. Introduction to article by Sistare et al.
    Morton D; Alden CL
    Toxicol Pathol; 2011 Jun; 39(4):715. PubMed ID: 21666102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.